58 related articles for article (PubMed ID: 1804672)
1. In vivo and in vitro inactivation of bovine surfactant by an anti-surfactant monoclonal antibody.
Eijking EP; Strayer DS; van Daal GJ; Tenbrinck R; Merritt TA; Hannappel E; Lachmann B
Eur Respir J; 1991 Nov; 4(10):1245-50. PubMed ID: 1804672
[TBL] [Abstract][Full Text] [Related]
2. Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo.
Strayer DS; Herting E; Sun B; Robertson B
Am J Respir Crit Care Med; 1996 Mar; 153(3):1116-22. PubMed ID: 8630554
[TBL] [Abstract][Full Text] [Related]
3. Lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide SP-B.
Suzuki Y; Robertson B; Fujita Y; Grossmann G; Kogishi K; Curstedt T
Int J Exp Pathol; 1992 Jun; 73(3):325-33. PubMed ID: 1622844
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of surfactant. I. Human alveolar surfactant.
Strayer DS; Hallman M; Merritt TA
Clin Exp Immunol; 1991 Jan; 83(1):35-40. PubMed ID: 1988229
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of surfactant. II. Porcine and bovine surfactants.
Strayer DS; Hallman M; Merritt TA
Clin Exp Immunol; 1991 Jan; 83(1):41-6. PubMed ID: 1988231
[TBL] [Abstract][Full Text] [Related]
6. Mixtures of low molecular weight surfactant proteins and dipalmitoyl phosphatidylcholine duplicate effects of pulmonary surfactant in vitro and in vivo.
Smith GB; Taeusch HW; Phelps DS; Keough KM
Pediatr Res; 1988 May; 23(5):484-90. PubMed ID: 3387170
[TBL] [Abstract][Full Text] [Related]
7. An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant.
McLean LR; Lewis JE; Krstenansky JL; Hagaman KA; Cope AS; Olsen KF; Matthews ER; Uhrhammer DC; Owen TJ; Payne MH
Am Rev Respir Dis; 1993 Feb; 147(2):462-5. PubMed ID: 8430972
[TBL] [Abstract][Full Text] [Related]
8. Surfactant as a carrier: influence of immunosuppressive agents on surfactant activity.
Gommers D; Haitsma JJ; Lachmann B
Clin Physiol Funct Imaging; 2006 Nov; 26(6):357-61. PubMed ID: 17042902
[TBL] [Abstract][Full Text] [Related]
9. The function of surfactant is impaired during the reimplantation response in rat lung transplants.
Erasmus ME; Petersen AH; Oetomo SB; Prop J
J Heart Lung Transplant; 1994; 13(5):791-802. PubMed ID: 7803420
[TBL] [Abstract][Full Text] [Related]
10. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant-associated hydrophobic protein SP-B.
Kobayashi T; Robertson B; Grossmann G; Nitta K; Curstedt T; Suzuki Y
Acta Paediatr; 1992 Sep; 81(9):665-71. PubMed ID: 1421904
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on the treatment of smoke inhalation injury with lung lavage and exogenous pulmonary surfactant].
Xie E; Yang Z; Li A
Zhonghua Wai Ke Za Zhi; 1997 Dec; 35(12):745-8. PubMed ID: 10677998
[TBL] [Abstract][Full Text] [Related]
12. Effects of antisurfactant antibodies on the course of mild respiratory distress syndrome.
Eijking EP; Strayer DS; van Daal GJ; Lachmann B
Pathobiology; 1991; 59(2):96-101. PubMed ID: 1907454
[TBL] [Abstract][Full Text] [Related]
13. Surfactant improves graft function after gastric acid-induced lung damage in lung transplantation.
Inci I; Hillinger S; Arni S; Jungraithmayr W; Inci D; Vogt P; Leskosek B; Hansen G; Weder W
Ann Thorac Surg; 2013 Mar; 95(3):1013-9. PubMed ID: 23261115
[TBL] [Abstract][Full Text] [Related]
14. Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome.
Danlois F; Zaltash S; Johansson J; Robertson B; Haagsman HP; van Eijk M; Beers MF; Rollin F; Ruysschaert JM; Vandenbussche G
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):779-87. PubMed ID: 11042134
[TBL] [Abstract][Full Text] [Related]
15. Increase of inactive intra-alveolar surfactant subtypes in lungs of asthmatic Brown Norway rats.
Schmiedl A; Hoymann HG; Ochs M; Menke A; Fehrenbach A; Krug N; Tschernig T; Hohlfeld JM
Virchows Arch; 2003 Jan; 442(1):56-65. PubMed ID: 12536315
[TBL] [Abstract][Full Text] [Related]
16. Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates.
Gortner L; Maroske W; Reiss I; Weller E
Arzneimittelforschung; 2006; 56(1):25-32. PubMed ID: 16478002
[TBL] [Abstract][Full Text] [Related]
17. Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity.
van 't Veen A; Gommers D; Mouton JW; Kluytmans JA; Krijt EJ; Lachmann B
Br J Pharmacol; 1996 Jun; 118(3):593-8. PubMed ID: 8762082
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia.
Ennema JJ; Kobayashi T; Robertson B; Curstedt T
Acta Anaesthesiol Scand; 1988 Nov; 32(8):665-71. PubMed ID: 3213391
[TBL] [Abstract][Full Text] [Related]
19. Direct interactions between nitrous oxide and exogenous pulmonary surfactant in vitro.
Sosnowski TR; GradoĊ L; Marraro GA
Exp Lung Res; 2004 Jun; 30(4):311-8. PubMed ID: 15204836
[TBL] [Abstract][Full Text] [Related]
20. Surfactant abnormality after endotoxin-induced lung injury in guinea-pigs.
Tahvanainen J; Hallman M
Eur J Respir Dis; 1987 Oct; 71(4):250-8. PubMed ID: 3319662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
